Programmed cell death (PCD) is a well conserved, genetically controlled process of cell suicide that occurs naturally during the life span of many organisms. Among the core molecular components that mediate apoptosis in C. elegans , the caspase CED-3 is a necessary activator of nearly all developmental PCD. Strong
ced-3(-) mutants show nearly no PCD and all cells that would normally die instead develop, differentiate, and integrate into the host organism's tissues. Despite extensive knowledge of the core cell death machinery, the pathways that mediate this event downstream of, or in parallel to, CED-3 are not clearly defined. Debilitating the function of the apoptotic suppressor ICD-1 (Bloss et al., Nature 424: 1066 (2003)) results in widespread cell death, which, like developmental PCD, requires the essential cell death activator CED-4. However, this apoptotic death does not require CED-3 activity. Based on these observations, we performed an RNAi screen for additional suppressors of
ced-3 -independent PCD which has revealed a set of ~130 candidate genes. Our investigation of these newly identified apoptotic suppressor candidates consists of three principal objectives: (1) We are currently categorizing the newly identified genes into genetic and phenotypic groups to establish classes of PCD repression. Genetic interactions with the core PCD machinery are being examined by performing candidate gene RNAi on
ced-3(-) and
ced-4(-) mutants. (2) We are applying Bayesian networking methods of bioinformatics to predict functional networks through which these genes may act in the organism. (3) Based on these studies, we are developing a refined list of prominent candidates that we intend to pursue by detailed mechanistic studies.